DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,949 | +2.0% | 76,377 | -1.3% | 2.23% | +6.2% |
| Q2 2023 | $18,576 | -5.9% | 77,402 | -1.2% | 2.10% | -10.4% |
| Q1 2023 | $19,751 | -4.5% | 78,366 | +0.6% | 2.34% | -7.8% |
| Q4 2022 | $20,676 | -99.9% | 77,901 | -1.0% | 2.54% | -7.1% |
| Q3 2022 | $20,323,000 | +1.8% | 78,681 | -0.0% | 2.73% | +7.8% |
| Q2 2022 | $19,956,000 | -14.8% | 78,716 | -1.4% | 2.54% | -2.7% |
| Q1 2022 | $23,415,000 | -11.3% | 79,824 | -0.6% | 2.61% | -2.4% |
| Q4 2021 | $26,411,000 | +1.3% | 80,274 | -6.2% | 2.67% | -8.0% |
| Q3 2021 | $26,061,000 | +13.7% | 85,602 | +0.2% | 2.90% | +13.3% |
| Q2 2021 | $22,917,000 | +20.9% | 85,397 | +1.4% | 2.56% | +12.5% |
| Q1 2021 | $18,951,000 | +1.6% | 84,198 | +0.3% | 2.28% | +0.0% |
| Q4 2020 | $18,649,000 | +1.1% | 83,951 | -2.0% | 2.28% | -7.3% |
| Q3 2020 | $18,454,000 | +20.6% | 85,700 | -1.0% | 2.46% | +10.9% |
| Q2 2020 | $15,307,000 | +26.0% | 86,565 | -1.4% | 2.22% | +7.9% |
| Q1 2020 | $12,152,000 | -10.0% | 87,800 | -0.2% | 2.06% | +10.5% |
| Q4 2019 | $13,504,000 | +8.9% | 87,985 | +2.5% | 1.86% | +2.4% |
| Q3 2019 | $12,401,000 | +1.5% | 85,862 | +0.4% | 1.82% | -0.9% |
| Q2 2019 | $12,219,000 | +7.7% | 85,492 | -0.6% | 1.83% | +3.7% |
| Q1 2019 | $11,349,000 | +33.7% | 85,967 | +4.4% | 1.77% | +15.6% |
| Q4 2018 | $8,489,000 | -2.8% | 82,325 | +2.4% | 1.53% | +12.4% |
| Q3 2018 | $8,732,000 | +12.7% | 80,360 | +2.3% | 1.36% | +2.8% |
| Q2 2018 | $7,751,000 | +4.8% | 78,545 | +4.0% | 1.32% | -0.7% |
| Q1 2018 | $7,396,000 | -2.3% | 75,540 | -7.4% | 1.33% | +2.7% |
| Q4 2017 | $7,573,000 | +12.2% | 81,585 | +3.7% | 1.30% | +8.8% |
| Q3 2017 | $6,747,000 | +15.0% | 78,660 | +13.2% | 1.19% | +7.9% |
| Q2 2017 | $5,865,000 | +2.7% | 69,500 | +4.1% | 1.10% | +1.3% |
| Q1 2017 | $5,709,000 | +7.9% | 66,745 | -1.8% | 1.09% | +4.4% |
| Q4 2016 | $5,291,000 | +5.4% | 67,975 | +6.1% | 1.04% | +5.6% |
| Q3 2016 | $5,020,000 | -14.3% | 64,040 | +10.4% | 0.99% | -13.9% |
| Q2 2016 | $5,860,000 | +4.6% | 58,019 | -1.6% | 1.15% | +5.8% |
| Q1 2016 | $5,600,000 | -47.3% | 58,944 | -48.4% | 1.09% | +3.8% |
| Q4 2015 | $10,618,000 | +121.4% | 114,178 | +102.4% | 1.05% | +6.4% |
| Q3 2015 | $4,795,000 | -3.8% | 56,410 | -2.7% | 0.98% | +1.8% |
| Q2 2015 | $4,985,000 | +0.7% | 57,970 | -0.4% | 0.97% | +1.6% |
| Q1 2015 | $4,949,000 | -1.5% | 58,220 | -0.3% | 0.95% | -2.9% |
| Q4 2014 | $5,024,000 | +13.7% | 58,418 | +0.5% | 0.98% | +6.4% |
| Q3 2014 | $4,419,000 | -3.9% | 58,143 | -0.1% | 0.92% | -4.8% |
| Q2 2014 | $4,597,000 | +8.3% | 58,193 | +2.9% | 0.97% | +4.9% |
| Q1 2014 | $4,243,000 | -1.7% | 56,568 | +0.9% | 0.92% | -2.6% |
| Q4 2013 | $4,317,000 | +10.5% | 56,068 | -1.0% | 0.95% | +1.1% |
| Q3 2013 | $3,907,000 | +14.9% | 56,618 | +4.9% | 0.94% | +10.4% |
| Q2 2013 | $3,401,000 | – | 53,990 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |